1. Home
  2. MODD vs VWAV Comparison

MODD vs VWAV Comparison

Compare MODD & VWAV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MODD
  • VWAV
  • Stock Information
  • Founded
  • MODD 1998
  • VWAV 2024
  • Country
  • MODD United States
  • VWAV United States
  • Employees
  • MODD N/A
  • VWAV N/A
  • Industry
  • MODD Industrial Specialties
  • VWAV Computer Software: Prepackaged Software
  • Sector
  • MODD Health Care
  • VWAV Technology
  • Exchange
  • MODD Nasdaq
  • VWAV Nasdaq
  • Market Cap
  • MODD 46.3M
  • VWAV 41.4M
  • IPO Year
  • MODD N/A
  • VWAV N/A
  • Fundamental
  • Price
  • MODD $0.71
  • VWAV $2.35
  • Analyst Decision
  • MODD
  • VWAV
  • Analyst Count
  • MODD 0
  • VWAV 0
  • Target Price
  • MODD N/A
  • VWAV N/A
  • AVG Volume (30 Days)
  • MODD 132.7K
  • VWAV 483.1K
  • Earning Date
  • MODD 08-13-2025
  • VWAV 01-01-0001
  • Dividend Yield
  • MODD N/A
  • VWAV N/A
  • EPS Growth
  • MODD N/A
  • VWAV N/A
  • EPS
  • MODD N/A
  • VWAV N/A
  • Revenue
  • MODD N/A
  • VWAV N/A
  • Revenue This Year
  • MODD N/A
  • VWAV N/A
  • Revenue Next Year
  • MODD N/A
  • VWAV N/A
  • P/E Ratio
  • MODD N/A
  • VWAV N/A
  • Revenue Growth
  • MODD N/A
  • VWAV N/A
  • 52 Week Low
  • MODD $0.63
  • VWAV $2.06
  • 52 Week High
  • MODD $2.65
  • VWAV $3.86
  • Technical
  • Relative Strength Index (RSI)
  • MODD 45.17
  • VWAV N/A
  • Support Level
  • MODD $0.68
  • VWAV N/A
  • Resistance Level
  • MODD $0.78
  • VWAV N/A
  • Average True Range (ATR)
  • MODD 0.06
  • VWAV 0.00
  • MACD
  • MODD 0.01
  • VWAV 0.00
  • Stochastic Oscillator
  • MODD 37.93
  • VWAV 0.00

About MODD Modular Medical Inc.

Modular Medical Inc is a development stage medical device company which focuses on the design, development, and commercialization of insulin pumps using modernized technology to increase pump adoption in the diabetes marketplace. The company's products seek to serve both the type 1 and the rapidly growing, especially in terms of device adoption, type 2 diabetes markets.

Share on Social Networks: